Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas.
about
Targeting Hsp90 in urothelial carcinomaCombined chemotherapy with gemcitabine and carboplatin for metastatic urothelial carcinomas in patients with high renal insufficiency.Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis.miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.Treatment of metastatic renal cell carcinoma and renal pelvic cancer.Remarkable response to neoadjuvant therapy with methotrexate, vinblastine, adriamycin, and Cisplatin for undifferentiated bladder carcinoma: a case report and literature review.MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.Cisplatin resistance by induction of aldo-keto reductase family 1 member C2 in human bladder cancer cellsAdseverin: a novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis.Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells.
P2860
Q27023406-2062C13C-22B9-4698-BB9D-4EDC8C0A35D0Q33403057-3186D951-7E64-47B8-BE78-C4F42DD06657Q33431220-0D0399A9-AE7D-425F-AD61-29B753F41B40Q35557027-005B68CC-09BB-4773-B38F-1F46901A1C4FQ36433289-719E326F-7E01-44C3-86F7-0E079C897763Q37863582-4FE103B1-BCFE-4D0A-B0A3-34E026BF510FQ38292628-6261B7BE-81B3-458E-8D12-88935A1FCF89Q38715517-B4B973C2-975B-4842-95DE-900FA01D0FC1Q39023990-00862278-4267-4AB8-BE10-81B5C0DEB918Q39408732-C5397F39-EE9D-4135-8353-0EB16452C281Q49213903-8C792648-00C8-42AF-9E60-31C71925FEF8
P2860
Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term results of combined ...... astatic urothelial carcinomas.
@ast
Long-term results of combined ...... astatic urothelial carcinomas.
@en
type
label
Long-term results of combined ...... astatic urothelial carcinomas.
@ast
Long-term results of combined ...... astatic urothelial carcinomas.
@en
prefLabel
Long-term results of combined ...... astatic urothelial carcinomas.
@ast
Long-term results of combined ...... astatic urothelial carcinomas.
@en
P2093
P1476
Long-term results of combined ...... astatic urothelial carcinomas.
@en
P2093
Akira Ozawa
Katsunori Aoki
Kenji Shimamoto
Masayoshi Yokoyama
Noriyoshi Miura
Nozomu Tanji
Tadahiko Kikugawa
Takayasu Nishida
Tatsumasa Ochi
Tetsuhiro Ikeda
P2888
P304
P356
10.1007/S10147-010-0069-2
P577
2010-03-26T00:00:00Z